Shockwave therapy is a non-invasive treatment used in wide areas of the medical field, such as urology, cardiology, orthopedics, and physiotherapy, among others. It is an alternative to orthopedic surgeries. In clinical studies, around 91% of patients reported positive results, including increased mobility, decreased chronic pain, and other health improvements. Shock wave therapy is used to treat a variety of musculoskeletal conditions, particularly those that affect medium to large tendons and their insertions on bone. This is a non-surgical treatment that works by delivering pulses of energy, targeted at specific damaged tissue within the abnormal tendon. Shock wave therapy stimulates cell regeneration and healing, increases blood flow to the affected area, and decreases local factors that can cause pain. Thus, there is an increasing demand for shock wave therapy devices all over the world.
Get FREE Sample Report with Latest Covid19 @ Analysis https://www.coherentmarketinsights.com/insight/request-sample/456
The major players operating in the global shockwave therapy devices market are CR Bard Inc., Seimens AG, Karl Storz GmbH, Cook Group Inc., Edaptms TMS, Medtrue Enterprise Co. Ltd., Olympus Corp., Dornier MedTech GmbH, Lumenis Ltd. , and Boston Scientific Corporation, among others.
Main market drivers:
The high prevalence of musculoskeletal disorders across the globe is expected to propel the growth of the Shockwave Therapy Devices market during the forecast period. Musculoskeletal disorders are the main contributor to disability worldwide. Musculoskeletal disorders are injuries or disorders of muscles, nerves, tendons, joints, cartilage and intervertebral discs. For example, according to the World Health Organization (WHO), approximately 1.71 billion people suffer from musculoskeletal disorders worldwide. Among musculoskeletal disorders, low back pain is the heaviest burden with a prevalence of 568 million people.
Additionally, increasing demand for shock wave therapy devices, growing geriatric population, and established healthcare infrastructure are expected to increase the growth of the shock wave therapy devices market. For example, in April 2019, Medytox Korea launched HNT Medical’s Carewave, Korea’s first extracorporeal shock wave equipment for erectile dysfunction, which is approved by the Ministry of Food and Pharmaceutical Safety.
COVID-19 impact analysis:
Many patients with COVID-19 (coronavirus disease) experience shortness of breath and severe chest pain. Radial extracorporeal shock wave therapy to support breathing in COVID-19. This type of non-invasive, non-pharmacological treatment can help many patients with COVID-19 or who still suffer from respiratory problems weeks after being infected with COVID-19, giving them back a quality of life. This therapy is considered to be safe, non-invasive, inexpensive, and without the dangers of surgery and postoperative pain. This in turn is expected to drive the growth of the market.
Get a PDF brochure with the latest information: https://www.coherentmarketinsights.com/insight/request-pdf/456
Key points to remember:
The Shockwave Therapy Devices Market is expected to post a XX% CAGR during the forecast period owing to the increasing incidence of cardiac ischemia, kidney stones and erectile dysfunction. For example, in January 2021, Alma announced the launch of Alma Duo, a revolutionary treatment for men. Alma Duo has been clinically validated to improve blood flow and bring spontaneity back to men’s lives using the benchmark in low-intensity extracorporeal shock wave therapy (LI-ESWT) focused on shock wave technology.
Among the regions, North America, Europe, and Asia-Pacific are expected to experience robust growth in the Shockwave Therapy Device market, owing to the increasing prevalence of musculoskeletal disorders, huge pool of patients with pain management, growing preference for non-invasive technologies, and increasing demand for technologically advanced shock wave therapy devices in these regions. For example, in February 2021, the United States Food and Drug Administration (FDA) approved the Shockwave Intravascular Lithotripsy (IVL) System for the treatment of severely calcified coronary artery plaques.
Reasons to buy this report
• Current and future outlook of the Global Shockwave Therapy Devices Market in developed and emerging markets
• The segment which is expected to dominate the market as well as the segment which holds the highest CAGR during the forecast period.
• Regions / countries expected to experience the fastest growth rates during the forecast period
• The latest developments, market shares and strategies used by the main market players
Chapter 1 Industry Overview
1.3 Scope of the research
1.4 Market Analysis by Regions
1.5 Global Shockwave Therapy Devices Market Size Analysis
11.6 COVID-19 Outbreak: Impact on Shockwave Therapy Device Industry
Chapter 2 Global Shockwave Therapy Devices Competition by Types, Applications and Major Regions and Countries
2.1 Global Shock Wave Therapy Devices (Volume & Value) by Type
2.3 Global Shockwave Therapy Devices (Volume & Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional production market analysis
Chapter 4 Global Sales, Consumption, Export, Import of Shockwave Therapy Devices by Regions
Chapter 5 North America Shockwave Therapy Devices Market Analysis
Chapter 6 East Asia Shockwave Therapy Devices Market Analysis
Chapter 7 Europe Shockwave Therapy Devices Market Analysis
Chapter 8 Southeast Asia Shockwave Therapy Device Market Analysis
Chapter 9 Southeast Asia Shockwave Therapy Devices Market Analysis
Chapter 10 Middle East Shockwave Therapy Device Market Analysis
Chapter 11 Africa Shockwave Therapy Device Market Analysis
Chapter 12 Oceania Shockwave Therapy Devices Market Analysis
Chapter 13 South America Shockwave Therapy Devices Market Analysis
Chapter 14 Business Profiles and Key Figures of Shock Wave Therapy Device Industry
Chapter 15 Global Shock Wave Therapy Device Market Forecast (2021-2028)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization focused on helping our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, we have an office at Global Financial Capital in the US, and business consultants in UK and Japan. Our clientele includes players from various industries in more than 150 countries around the world. We pride ourselves on serving clients the full length and breadth of the horizon, from Fortune 500 companies to nonprofits and startups looking to gain a foothold in the market. We excel in delivering unmatched actionable market insights across a variety of industry verticals, including chemicals and materials, healthcare, food and beverage, consumer goods, packaging, semiconductors, software and services, telecommunications and automotive. We offer syndicated market intelligence reports, custom research solutions, and advisory services.
Consistent market information
1001 4th Ave, # 3200 Seattle, WA 98154, USA
Email: [email protected]
United States of America: + 1-206-701-6702
United Kingdom: + 44-020-8133-4027
Japan: + 050-5539-1737
India: + 91-848-285-0837